产品详情
所在位置: 首页> 产品目录> 一抗>
查看大图

  • 产品名称：anti-PlexinDomainContaining1(PLXDC1)(AA466-494),(C-Term)antibody

  • 产品型号：
  • 产品厂商：半导体
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
anti-PlexinDomainContaining1(PLXDC1)(AA466-494),(C-Term)antibody
详情介绍：
Immunogen This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
Clone RB30617
Purification This antibody is purified through a protein A column, followed by peptide affinity purification. Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
Alternative Name PLXDC1 (PLXDC1 Antibody Abstract)
Background Plays a critical role in endothelial cell capillary morphogenesis.

Synonyms: PLXDC1, TEM3, TEM7, Plexin domain-containing protein 1, Tumor endothelial marker 3, Tumor endothelial marker 7
NCBI Accession NP_065138
UniProt Q8IUK5
Application Notes WB: 1:1000
Restrictions For Research Use only
Format Liquid
Concentration 0.4 mg/mL
Buffer Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Supplier Images
Western Blotting (WB) image for anti-Plexin Domain Containing 1 (PLXDC1) (AA 466-494), (C-Term) antibody (ABIN1881662) PLXDC1 Antibody (C-term) (ABIN1881662) western blot analysis in WiDr cell line lysate...
Product cited in: Halder, Ossendorf, Maran, Yaszemski, Bolander, Fuchs, Sarkar: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, 2009 (PubMed).

Yamaji, Yoshida, Ishikawa, Sengoku, Sato, Yoshida, Kuwahara, Ohuchida, Oki, Enaida, Fujisawa, Kono, Ishibashi: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, 2008 (PubMed).

Fuchs, Mahlum, Halder, Maran, Yaszemski, Bode, Bolander, Sarkar: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." in: Gene, Vol. 399, Issue 2, pp. 137-43, 2007 (PubMed).

Nanda, Buckhaults, Seaman, Agrawal, Boutin, Shankara, Nacht, Teicher, Stampfl, Singh, Vogelstein, Kinzler, St Croix: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." in: Cancer research, Vol. 64, Issue 23, pp. 8507-11, 2004 (PubMed).